Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
An initial medical office visit or telemedicine visit is required to begin this therapy
Treatment with MOUNJARO 10 mg and 15 mg once weekly for 52 weeks resulted in a statistically significant reduction in HbA1c compared with insulin glargine once daily (see Table 7)
Usage of the CCR2/CCR5 inhibitor cenicriviroc was shown to reduce two-year liver fibrosis progression in a clinical trial of MASH (NCT02217475)
however, no approved therapy simultaneously targets these interconnected mechanisms
US$ 26.53
US$ 24.35
US$ 26.17
US$ 28.45
